HopeStage
Back to all studies
CompletedNCT07432815

Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant

Medication studyAges 18–60Egypt
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 1, 2026
Recruitment status
Completed
Enrollment listed in the registry
40
Sponsor
Cairo University
Sponsor type
University
Study type
Drug
Intervention type
Combination product, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Egypt
Age range
From 18 Years to 60 Years
Official registry ID
NCT07432815
Official title
Show the full official title

Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant, A Randomized Controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Cairo

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Cairo University, a university.

Did this study involve medication?

Yes. The study involved medication, including Methotrexate.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies